German Merck to spend $110M on new gene therapy facility in California

German Merck to spend $110M on new gene therapy facility in California

Source: 
BioPharma Dive
snippet: 

Merck KGaA plans to spend 100 million euros, or about $110 million, to build a new facility in Carlsbad, California, that will focus on viral vector and gene therapy production.